Pulmonx Corporation (FRA:4NI)

Germany · Delayed Price · Currency is EUR

1.390

-0.050 (-3.47%)

Last updated: Jan 30, 2026, 8:12 AM CET

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Interventional Pulmonology	83.79M
Interventional Pulmonology Growth	22.01%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	56.47M
United States Growth	22.97%
Europe, Middle-East and Africa	22.33M
Europe, Middle-East and Africa Growth	61.31%
Asia Pacific	4.44M
Asia Pacific Growth	46.84%
Other International	556.00K
Other International Growth	39.35%